Approval · Notice of Compliance 29296 · 2022
ZIRABEV: Notice of Compliance 29296
Issued October 24, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29296
- Date
- October 24, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Established conditions for the drug product manufacturing process
- Canadian reference product
- AVASTIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZIRABEV | Not yet assigned | — |
Medicinal ingredients
- BEVACIZUMAB 25 MG per ML